# Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes

> **NCT01363609** · NA · COMPLETED · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 50 (actual)

## Conditions studied

- Obesity
- Type 2 Diabetes

## Interventions

- **DRUG:** Liraglutide treatment 12 weeks
- **DRUG:** insulin glargine treatment
- **DRUG:** GLP-1 receptor antagonist

## Key facts

- **NCT ID:** NCT01363609
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363609, "Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01363609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*